Pharmaceutical Commerce - June 2019
Your serialization systems aren’t as interoperable as you might think
FDA-accepted pilot projects hope to demonstrate how industry compliance could be realized by the 2023 deadline
New science breakthroughs, and easy access to financing, propel this year’s M&A and licensing market
Will retain position until May 2020
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
BoomRx Expands Access to Oral Semaglutide and Tirzepatide Using Nanoemulsion Delivery
2
The Hidden Economics of Health Insurance Affordability
3
Pharma Pulse: Novartis Warns of Trade Fragmentation; Hospital M&A Hits Record Low; Copay Shock Warning
4
Evaluate’s 2026 Pharma Forecast Signals Cautious Recovery, Rising M&A, and GLP-1 Market Shifts
5